myelodysplastic syndrome
A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001) [ ]
Term info
myelodysplastic syndrome
- MDS
- dysmyelopoietic syndrome
- hematopoeitic - myelodysplastic syndrome (MDS)
- myelodysplasia
- myelodysplastic neoplasm
- myelodysplastic syndrome
- myelodysplastic syndrome, somatic
- myelodysplastic syndrome/neoplasm
- myelodysplastic syndromes
- oligoblastic leukemia
- preleukemia
- smoldering leukemia
disease_grouping, ordo_group_of_disorders
http://identifiers.org/meddra/10028532
http://purl.obolibrary.org/obo/Orphanet_52688, https://omim.org/entry/614286, http://linkedlifedata.com/resource/umls/id/C3463824, http://purl.obolibrary.org/obo/NCIT_C3247, http://linkedlifedata.com/resource/umls/id/C0033027, http://purl.obolibrary.org/obo/DOID_0050908, http://identifiers.org/snomedct/109995007
true
myelodysplastic syndrome, susceptibility to
EFO:0000198
https://github.com/monarch-initiative/mondo/issues/4521